- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Conduct Disorder in New Zealand
Total 16251 results
-
AmgenCompletedDiabetes MellitusUnited States, Puerto Rico, Poland, Estonia, Czech Republic
-
Novo Nordisk A/STerminatedDiabetes Mellitus, Type 2 | DiabetesUnited States
-
Santhera PharmaceuticalsCompletedLeber's Hereditary Optic Neuropathy (LHON)United States, United Kingdom, Spain, Poland, Austria, Belgium, Bulgaria, Germany, Italy, Portugal
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIndia, Japan, Russian Federation, Spain, Sweden, Argentina, Hungary, Norway, South Africa, Turkey, Bulgaria, Romania, Thailand, Portugal, Hong Kong, Mexico, Ukraine, Czechia
-
AstraZenecaCompletedHyperlipidemiaUnited States, Bulgaria, South Africa, Germany, Hungary, Romania, Canada, Denmark, Mexico, Italy, Brazil
-
Inventiva PharmaActive, not recruitingDiabetes Mellitus, Type 2 | NASH - Nonalcoholic SteatohepatitisUnited States, Belgium, France, Netherlands, United Kingdom
-
Merz Pharmaceuticals GmbHRecruitingLower Limb or Combined Lower Limb and Upper Limb Spasticity Due to Stroke or Traumatic Brain InjuryUnited States, Belgium, Czechia, France, Germany, Italy, Poland, Spain, United Kingdom, Australia, Hungary, Norway, Switzerland, Slovakia, Ukraine, Russian Federation
-
AVEO Pharmaceuticals, Inc.Astellas Pharma IncTerminatedMetastatic Renal Cell CarcinomaFrance, United Kingdom, Germany, Spain, Belgium, United States, Italy
-
AviGenicsCompletedBreast Cancer | NeutropeniaUnited States, India
-
Novo Nordisk A/SRecruitingAlcohol-related Liver DiseaseCzechia, Denmark, Italy, Netherlands, Canada, Spain, United States, Australia, Japan, Greece, France, Poland, Bulgaria, Germany
-
AstraZenecaQuintiles, Inc.CompletedType 2 DiabetesUnited States, Korea, Republic of, India, Russian Federation, Brazil, Mexico, South Africa, Philippines
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Chile, Czech Republic, Denmark, France, Germany, Hungary, Lithuania, Mexico, Poland, Romania, Slovakia, Sweden
-
Hoffmann-La RocheCompletedDiabetes Mellitus Type 2Canada, United States, Hungary, Poland, Bulgaria, Croatia, Germany, Mexico, Guatemala, Australia
-
GlaxoSmithKlineWithdrawnType 2 Diabetes MellitusUnited States
-
GlaxoSmithKlineCompletedDiabetes Mellitus, Type 2United States, Germany, Canada, Belgium, Denmark, Spain, Ireland, Netherlands, United Kingdom, Hungary, Italy, France, Austria, Czechia, Norway, Finland, Sweden
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Ovarian Carcinoma | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Serous Cystadenocarcinoma | Fallopian Tube Carcinoma | Primary Peritoneal Carcinoma | Malignant Ovarian Mixed Epithelial Tumor | Ovarian Brenner Tumor | Ovarian Mucinous Cystadenocarcinoma and other conditionsUnited States
-
Sarepta Therapeutics, Inc.Hoffmann-La RocheRecruitingDuchenne Muscular DystrophyBelgium, United States, Japan, Spain, Italy, United Kingdom
-
Gilead SciencesCompletedType 2 Diabetes MellitusUnited States, Russian Federation, Thailand, Serbia, Poland, Hungary, Malaysia, South Africa, Ukraine, Czech Republic, Romania, Slovakia
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany, United States, India, Israel, Italy, Russian Federation, Japan, Finland, Serbia, Turkey, Bulgaria, Estonia, Czechia, Lithuania, Ukraine, Poland, Latvia, Puerto Rico
-
PfizerCompletedLymphoma, Follicular | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Non-Hodgkin | Carcinoma, Renal Cell | Carcinoma, Non-Small-Cell Lung | Malignant Melanoma | Carcinoma, Squamous Cell of Head and NeckUnited States, Australia, Japan, France, Italy
-
Provention Bio, a Sanofi CompanyActive, not recruitingDiabetes Mellitus, Type 1United States, Belgium, Canada, Czechia, France, Germany, Poland, United Kingdom
-
GlaxoSmithKlineCompletedAsthmaUnited States, Argentina, Canada, France, Netherlands, Spain, Ukraine, Bulgaria, Estonia, Belgium, Peru, Russian Federation, Germany, Greece, Czechia, Italy, United Kingdom, Norway, Slovakia
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedLung Diseases | Respiratory Distress Syndrome, AdultUnited States, Canada
-
NovartisCompletedParkinson's DiseaseUnited States, Canada, Czechia, Israel, Italy, Poland, Portugal, Turkey
-
AstraZenecaCompletedDiabetes MellitusUnited States, Brazil, Bulgaria, France, Italy, Mexico, Hungary, Romania, Denmark, Argentina, Canada
-
The Medicines CompanyCompletedElevated Cholesterol | Heterozygous Familial HypercholesterolemiaUnited States, Canada, Czechia, Denmark, Netherlands, South Africa, Spain, Sweden
-
Daiichi Sankyo, Inc.CompletedDiabetes Mellitus, Type 2United States
-
National Institute of Allergy and Infectious Diseases...CompletedHIV Infections | LipodystrophyUnited States, Puerto Rico
-
Kinevant Sciences GmbHRoivant Sciences, Inc.Completed
-
Eli Lilly and CompanyCompletedType 2 Diabetes | Chronic Kidney DiseaseMexico, United States, Hungary, Ukraine, Brazil, Spain, Romania, South Africa, Poland
-
Bristol-Myers SquibbCompletedMyeloid Leukemia, Chronic, Chronic-PhaseUnited States, Australia, France, Germany, Italy, Korea, Republic of, Sweden, Taiwan, Spain, Austria, Denmark, Belgium, Canada, Ireland, Switzerland, Netherlands, Peru, United Kingdom, South Africa, Argentina, Philippines, Singapore, Russian Federation and more
-
Population Health Research InstituteRecruitingAtrial Fibrillation | Intracranial HemorrhagesSpain, Germany, United States, Belgium, United Kingdom, Switzerland, Egypt, Canada, Austria, China, Czechia, India, Nepal, Portugal, Argentina
-
Solvay PharmaceuticalsCompletedHyperlipidemiaCzech Republic, Denmark, France, Germany, Hungary, Netherlands, Poland, Ukraine
-
SanofiCompletedType 2 Diabetes MellitusEstonia, Italy, Israel, United States, Canada, Germany, Romania, Slovakia, Spain
-
Novartis PharmaceuticalsActive, not recruitingParoxysmal Nocturnal HemoglobinuriaUnited States, Germany, France, United Kingdom, Spain, Korea, Republic of, Turkey, Italy
-
AmgenCompletedLeukemia, Acute LymphoblasticItaly, United Kingdom, Belgium, Mexico, Germany, Russian Federation, Turkey, Spain, Australia, Poland, Austria, Czechia, France, Portugal, Israel, Denmark, Brazil, Romania, Sweden, Switzerland, Norway, Netherlands, Argentina, Greece
-
Sanofi Pasteur, a Sanofi CompanyCompletedMeasles | Pertussis | Tetanus | Diphtheria | PolioUnited States, Puerto Rico
-
Avidity Biosciences, Inc.RecruitingPhase 1/2 Study of AOC 1020 in Adults With Facioscapulohumeral Muscular Dystrophy (FSHD) (FORTITUDE)Muscular Dystrophies | Muscular Dystrophy, Facioscapulohumeral | FSHD | Facio-Scapulo-Humeral Dystrophy | FMD | Facioscapulohumeral Muscular Dystrophy 1 | FSHD2 | FSHD1 | FMD2 | Fascioscapulohumeral Muscular Dystrophy | Fascioscapulohumeral Muscular Dystrophy Type 1 | Fascioscapulohumeral Muscular Dystrophy... and other conditionsUnited States, United Kingdom, Canada
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedFallopian Tube Cancer | Ovarian Clear Cell Cystadenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Serous Cystadenocarcinoma | Stage IV Ovarian Epithelial Cancer | Primary Peritoneal Cavity Cancer | Brenner Tumor | Stage II Ovarian Epithelial Cancer | Stage III Ovarian Epithelial Cancer | Ovarian... and other conditionsUnited States, Japan
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Active, not recruitingMetastatic Renal Cell Carcinoma | Chronic Kidney Disease | Stage IV Renal Cell Cancer AJCC v8 | Cardiovascular Disorder | Metastatic Thyroid Gland Medullary Carcinoma | Stage IV Thyroid Gland Medullary Carcinoma AJCC v8 | Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8 | Stage IVB Thyroid Gland... and other conditionsUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)Terminated
-
Johnson & Johnson Pharmaceutical Research & Development...PharmaMarCompletedOvarian CancerUnited States, France, Poland, United Kingdom, China, Belgium, Germany, Hong Kong, Taiwan, Spain, Canada, Netherlands, Sweden, Korea, Republic of, Singapore, Russian Federation, Argentina, Brazil, Chile, Australia
-
Pharnext S.C.A.Premier Research Group plc; Eurofins Optimed; Synteract HCR (Syneos Health); Gr... and other collaboratorsActive, not recruitingCharcot-Marie-Tooth Disease, Type IAUnited States, Belgium, Canada, France, Netherlands, Spain, United Kingdom
-
BayerCompletedDiabetic NephropathiesHong Kong, Australia, Spain, Portugal, United States, France, Canada, Netherlands, Austria, Finland, Poland, Taiwan, Hungary, Israel, Italy, South Africa, Sweden, Bulgaria, Germany, Denmark, Czechia, Korea, Republic of, Norway
-
Ultragenyx Pharmaceutical IncRecruitingOTC DeficiencyUnited States, Portugal, Italy, Spain, United Kingdom, Japan, Canada, Germany, France, Argentina, Netherlands, Brazil
-
Novartis PharmaceuticalsCompletedCentral Retinal Vein Occlusion | Macular EdemaGreece, Hungary, Turkey, Australia, Austria, Netherlands, United Kingdom, Italy, Spain, Ireland, Portugal, Slovakia, Canada, Switzerland, Czech Republic, Poland, Denmark, Sweden
-
Kinevant Sciences GmbHActive, not recruitingSarcoidosis, PulmonaryUnited States, Belgium, France, Germany, Netherlands, Turkey, United Kingdom
-
Biohaven Pharmaceuticals, Inc.Active, not recruitingSpinocerebellar Ataxia Type 3 | Spinocerebellar Ataxias | Spinocerebellar Ataxia Type 1 | Spinocerebellar Ataxia Type 2 | Spinocerebellar Ataxia Type 6 | Spinocerebellar Ataxia Type 10 | Spinocerebellar Ataxia Type 7 | Spinocerebellar Ataxia Type 8United States, China
-
Novartis PharmaceuticalsTerminatedAcute Heart FailureChina, Colombia, Korea, Republic of, Germany, Taiwan, Turkey, Spain, Egypt, Netherlands, United States, Australia, Switzerland, Thailand, Lebanon, Bulgaria, Israel, Argentina, Mexico, Greece, India, Russian Federation, Canada, United... and more
-
Mannkind CorporationTerminatedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1 | AsthmaBrazil, United States, Canada, Poland, Russian Federation, Argentina, Czech Republic, Mexico, Spain, Ukraine, United Kingdom